In this comprehensive overview (see Methods and the search methodology in Supplementary Section 1), we aim to identify and describe pre-clinical, mechanistic and clinical studies on the effects of GLP-1RAs in cognitive and mental health disorders, and to provide a summary of available evidence and future perspectives
We need to distinguish science-based solutions from marketing hype. Meet the experts : Dendy Engelman, MD, is a New York City-based dermatologist and director of dermatologic surgery at Metropolian Hospital
In the ATTAIN-MAINTAIN trial, 205 patients taking tirzepatide and 171 patients taking semaglutide were randomized to take orforglipron or placebo (no active drug) daily for a year
Class 3 is also categorized as extreme or severe obesity (CDC, 2022)
neuromuscular disorders that may cause muscle wasting, such as muscular dystrophy, spinal muscular atrophy or amyotrophic lateral sclerosis
These vouchers followed agreements from Novo Nordisk and Lilly to cut prices on the drugs for Medicaid and Medicare patients
